Public list: Pharma Startups (4733) Cancer Therapeutics (1136)
eFFECTOR Therapeutics is an early stage company focused on the discovery and development of new small molecule cancer therapeutics. eFFECTOR is developing translation regulators to selectively block disregulated translation impacting tumor growth and...Show all
Company (Alive / Active)
Phone: 858-442-4861
11180 Roselle Street
Suite A
San Diego, 92121
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Eif4a-inhibiting compounds and methods related thereto | Nov 22, 2016 | May 01, 2018 | Patent |
| Mnk inhibitors and methods related thereto | Jun 02, 2017 | Nov 14, 2017 | Patent |
| Mnk inhibitors and methods related thereto | Jun 21, 2016 | Jun 06, 2017 | Patent |
| Mnk inhibitors and methods related thereto | Nov 10, 2017 | Application | |
| Mnk biomarkers and uses thereof | Dec 23, 2016 | Application |
Download PDF